CLP1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.420200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.259180E-01
Normal-vs-Stage2
2.632400E-01
Normal-vs-Stage3
1.807420E-01
Normal-vs-Stage4
9.661600E-01
Stage1-vs-Stage2
5.043400E-01
Stage1-vs-Stage3
7.355600E-01
Stage1-vs-Stage4
1.758160E-01
Stage2-vs-Stage3
3.218600E-01
Stage2-vs-Stage4
1.812390E-01
Stage3-vs-Stage4
2.138800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.157800E-01
Normal-vs-AfricanAmerican
8.113000E-01
Normal-vs-Asian
1.243190E-01
Caucasian-vs-AfricanAmerican
1.599160E-01
Caucasian-vs-Asian
9.484400E-01
AfricanAmerican-vs-Asian
1.642800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.413430E-01
Normal-vs-Female
4.002000E-01
Male-vs-Female
6.412400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.390840E-01
Normal-vs-Age(41-60Yrs)
3.446600E-01
Normal-vs-Age(61-80Yrs)
2.281400E-01
Normal-vs-Age(81-100Yrs)
1.671630E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.325600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.411800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.280800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.552180E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.858400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.694400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.168400E-02
Normal-vs-Daily Drinker
9.661800E-02
Normal-vs-Weekly Drinker
5.556000E-01
Normal-vs-Occasional Drinker
4.912400E-01
Normal-vs-Social Drinker
2.435000E-01
Non Drinker-vs-Daily Drinker
8.887200E-01
Non Drinker-vs-Weekly Drinker
1.586390E-01
Non Drinker-vs-Occasional Drinker
4.437500E-03
Non Drinker-vs-Social Drinker
1.249160E-01
Daily Drinker-vs-Weekly Drinker
1.792970E-01
Daily Drinker-vs-Occasional Drinker
3.012300E-02
Daily Drinker-vs-Social Drinker
2.668600E-01
Weekly Drinker-vs-Occasional Drinker
7.394800E-01
Weekly Drinker-vs-Social Drinker
6.866800E-01
Occasional Drinker-vs-Social Drinker
3.279800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.348000E-01
Normal-vs-Grade 2
7.782800E-01
Normal-vs-Grade 3
7.790800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.035580E-01
Grade 1-vs-Grade 3
1.410840E-01
Grade 1-vs-Grade 4
7.348000E-01
Grade 2-vs-Grade 3
9.888400E-01
Grade 2-vs-Grade 4
7.782800E-01
Grade 3-vs-Grade 4
7.790800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.637200E-01
Normal-vs-NonDiabetic
1.616600E-01
Diabetic-vs-NonDiabetic
7.690200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.128800E-01
Normal-vs-NoPancreatitis
2.047200E-01
Pancreatitis-vs-NoPancreatitis
9.198600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.629240E-01
Normal-vs-N1
2.892400E-01
N0-vs-N1
5.273600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.575800E-01
Normal-vs-TP53-NonMutant
3.770400E-01
TP53-Mutant-vs-TP53-NonMutant
2.213400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
